IRIS
MARRELLI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.311
EU - Europa 16.505
AS - Asia 2.808
AF - Africa 118
SA - Sud America 53
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 17
Totale 37.842
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.268
GB - Regno Unito 4.950
IE - Irlanda 3.107
CN - Cina 2.039
UA - Ucraina 1.744
IT - Italia 1.642
SE - Svezia 1.508
FR - Francia 985
RU - Federazione Russa 865
DE - Germania 789
FI - Finlandia 472
SG - Singapore 418
ES - Italia 135
VN - Vietnam 98
BE - Belgio 84
CI - Costa d'Avorio 68
IN - India 52
IR - Iran 40
CA - Canada 35
RO - Romania 35
TR - Turchia 33
NL - Olanda 27
AU - Australia 26
MU - Mauritius 26
PT - Portogallo 25
CZ - Repubblica Ceca 22
BR - Brasile 21
EG - Egitto 18
JP - Giappone 17
EU - Europa 16
KR - Corea 16
PL - Polonia 14
CH - Svizzera 12
PH - Filippine 11
AT - Austria 10
GR - Grecia 10
SA - Arabia Saudita 10
CL - Cile 9
KG - Kirghizistan 9
BG - Bulgaria 8
SI - Slovenia 8
AR - Argentina 7
HK - Hong Kong 7
LV - Lettonia 7
AZ - Azerbaigian 6
DK - Danimarca 6
KZ - Kazakistan 6
MY - Malesia 6
AE - Emirati Arabi Uniti 5
EC - Ecuador 5
ID - Indonesia 5
LU - Lussemburgo 5
AL - Albania 4
BD - Bangladesh 4
EE - Estonia 4
ET - Etiopia 4
IL - Israele 4
LT - Lituania 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
PE - Perù 4
PK - Pakistan 4
RS - Serbia 4
HU - Ungheria 3
NO - Norvegia 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TW - Taiwan 3
UY - Uruguay 3
AM - Armenia 2
BO - Bolivia 2
CY - Cipro 2
IM - Isola di Man 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
LC - Santa Lucia 2
LK - Sri Lanka 2
MX - Messico 2
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
CM - Camerun 1
CO - Colombia 1
FK - Isole Falkland (Malvinas) 1
HR - Croazia 1
IQ - Iraq 1
IS - Islanda 1
JM - Giamaica 1
MA - Marocco 1
MC - Monaco 1
UZ - Uzbekistan 1
Totale 37.842
Salva come PNG Salva come JPEG
Città #
Southend 4.666
Fairfield 3.121
Dublin 3.081
Chandler 1.612
Jacksonville 1.508
Ashburn 1.412
Woodbridge 1.370
Wilmington 1.175
Seattle 1.118
Houston 1.078
Cambridge 989
Ann Arbor 780
Princeton 575
Nanjing 473
Beijing 379
Siena 351
Singapore 253
Boardman 230
San Mateo 226
New York 187
Helsinki 185
San Diego 161
Shanghai 161
Nanchang 138
Shenyang 137
Málaga 125
Moscow 120
Dong Ket 89
Hebei 89
Tianjin 86
Brussels 79
Florence 78
Abidjan 68
Jiaxing 66
Düsseldorf 65
Changsha 63
Kunming 60
Rome 56
London 50
Dearborn 49
Jinan 49
Menlo Park 48
Milan 46
Norwalk 46
Venezia 46
Ningbo 44
San Francisco 33
Zhengzhou 33
Falls Church 32
Los Angeles 32
Dallas 31
Washington 31
Guangzhou 30
Höst 28
Hangzhou 27
Port Louis 26
Redwood City 21
Fremont 20
Taizhou 20
Tappahannock 20
Toronto 20
Changchun 17
Santa Clara 17
Brno 15
Lappeenranta 15
Naples 15
Serra 15
Izmir 14
Porto 14
Andover 13
Genoa 13
Livorno 13
Munich 13
Verona 13
Zanjan 13
Bologna 12
Hounslow 12
Indiana 12
Kilburn 12
Lanzhou 10
Leawood 10
Mestre 10
Phoenix 10
Riyadh 10
Sacramento 10
Tehran 10
Tokyo 10
Vienna 10
Bishkek 9
Canberra 9
Chicago 9
Palermo 9
Redmond 9
Turin 9
Viareggio 9
Arezzo 8
Berlin 8
Frankfurt am Main 8
Fuzhou 8
Lisbon 8
Totale 27.633
Salva come PNG Salva come JPEG
Nome #
Patologie del duodeno 452
Gastric cancer maximum tumour diameter reduction rate at CT examination as a radiological index for predicting histopathological regression after neoadjuvant treatment: A multicentre GIRCG study 223
Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) 199
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer 198
C-Met targeting in advanced gastric cancer: An open challenge 195
354. KRAS mutation in gastric cancer- molecular, and clinico-pathological characteristic 191
Clinical significance of multifocal and multicentric breast cancers and choice of surgical treatment: a retrospective study on a series of 1158 cases 186
Hyperthermic intrathoracic chemotherapy after extended pleurectomy and decortication for malignant pleura mesothelioma: An observational study on outcome and microcirculatory changes 186
Familial aggregation of gastric cancer with microsatellite instability** 184
65. Molecular surgery for gastric cancer-role of microsatellite instability in elderly patients 181
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives 179
Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer 178
Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer 176
Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study 172
KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status 172
Robotic versus laparoscopic gastrectomy for gastric cancer: protocol for umbrella review of systematic reviews and meta-analyses 171
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer 170
611. Gastric cancer patients with familial aggregation of gastric cancer and Lynch syndrome associated cancers with microsatellite instability 170
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015 170
Recurrence after surgery in esophago-gastric junction adenocarcinoma: Current management and future perspectives 170
Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer 170
Comparison between 7th and 8th edition of AJCC TNM staging system for gastric cancer: Old problems and new perspectives 169
613. Lymph node metastases in microsatellite unstable gastric cancer 168
612. Molecular background of high risk and low risk areas of gastric cancer in Italy 167
610. Heterogeneity of new molecular gastric cancer classifications. Clinico-pathological characteristic 167
353. PIK3CA mutation in gastric cancer and the role of different codon mutations in the new molecular division of that neoplasm 166
Is tissue inhibitor of metalloproteinase-1 a new prognosticator for breast cancer? An analysis of 266 cases 165
From digital world to real life: A robotic approach to the esophagogastric junction with a 3D printed model 165
E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. 164
Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer 164
Clinical evaluation of the Mannheim Prognostic Index in post-operative peritonitis: a prospective cohort study 164
Naso-gastric or naso-jejunal decompression after partial distal gastrectomy for gastric cancer. Final results of a multicenter prospective randomized trial 163
Il ruolo della chemioipertermia nel carcinoma del colon-retto 162
Molecular key to understand the gastric cancer biology in elderly patients—The role of microsatellite instability 162
530. Minimally invasive surgery for the treatment of colo-rectal adenocarcinoma: Laparoscopic and robotic approach 162
Trattamento chirurgico radicale di emangiopericitoma retroperitoneale recidivo: case report. 160
The pattern of lymph node metastases in microsatellite unstable gastric cancer 159
Re-evaluation of Mannheim prognostic index in perforative peritonitis: Prognostic role of advanced age. A prospective cohort study 159
338. Comparing characteristics and survival outcomes of adolescent and young adults to mature patients with colorectal cancer 159
Family history of gastric cancer: a correlation between epidemiologic findings and clinical data 158
Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an italian family 158
Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer 157
CA 19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions 156
Clinical impact of molecular classifications in gastric cancer 155
Gastric Cancer and Synchronous Hepatic Metastases: Is It Possible to Recognize Candidates to R0 Resection? 154
A new way to experience the International Gastric Cancer Association Congress: the Web Round Tables 154
Gastric stump carcinoma after distal subtotal gastrectomy for early gastric cancer: Experience of 541 patients with long-term follow-up 154
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer 153
Is sleeve gastrectomy a therapeutic procedure for all obese patients? 152
Risk factor analysis for involvement of resection margins in gastric and esophagogastric junction cancer: an Italian multicenter study 152
Number of lymph nodes assessed has no prognostic impact in node-negative rectal cancers after neoadjuvant therapy. Results of the “Italian Society of Surgical Oncology (S.I.C.O.) Colorectal Cancer Network” (SICO-CCN) multicentre collaborative study 152
High-risk and low-risk gastric cancer areas in Italy and its association with microsatellite instability 152
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study 151
Duodenal gastrointestinal stromal tumor: From clinicopathological features to surgical outcomes 150
External Validation of a Score Predictive of Recurrence after Radical Surgery for Non-Cardia Gastric Cancer: Results of a Follow-Up Study 149
E-cadherin and hereditary diffuse gastric cancer. 148
Clinical and oncological value of preoperative BMI in gastric cancer patients: A single center experience 148
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience 147
Complications after surgery for gastric cancer in patients aged 80 years and over 146
Robotic single docking total colectomy for ulcerative colitis: First experience with a novel technique 145
Primary non-Hodgkin's breast lymphoma: surgical approach. 144
28. Role of neoadjuvant chemotherapy with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for treatment of primary ovarian cancer with peritoneal carcinomatosis 144
International consensus on a complications list after gastrectomy for cancer 144
K-RAS mutation in gastric cancer and its link with microsatellite instability status 144
Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer 143
Potential impact of molecular classification on tailored lymphadenectomy for gastric cancer 143
Elastofibroma dorsi: three cases of personal experience 143
Accuracy of MDCT in the Preoperative Definition of Peritoneal Cancer Index (PCI) in Patients with Advanced Ovarian Cancer Who Underwent Peritonectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) 143
Breast cancer local recurrence: risk factors and prognostic relevance of early time to recurrence 143
PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene 143
Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments. 143
A rare case of primary small bowel adenocarcinoma with intussusception. 142
Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results 142
Western perspective and epidemiology of gastric cancer 142
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer 141
Targeting VEGFR-2 in Metastatic Gastric Cancer: Results From a Literature-Based Meta-Analysis 141
High accuracy of multislices computed tomography (MSCT) for para-aortic lymph node metastases from gastric cancer: a prospective single-center study. 141
Super-extended (D3) lymphadenectomy in advanced gastric cancer. 140
A clinical case of duodenal gastrointestinal stromal tumor with a peculiarity in the surgical approach. 140
Assessment of Microsatellite Instability in Familial Gastric Cancer 140
High incidence of familial gastric cancer in Tuscany, a region in Italy. 139
Gastro-pleuro-pericardial fistula following combined radiation and chemotherapy for lung metastases from renal cell carcinoma: report of a case 138
Gastric stump cancer after distal gastrectomy for benign disease: Clinicopathological features and surgical outcomes 138
Factors influencing survival after hepatectomy for metastases from gastric cancer 138
Accuracy of MDCT in preoperative definition of maximum tumour diameter in patients with gastric cancer 138
Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference 138
Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer 138
Presacral ganglioneuroma: a case report and review of literature 137
Krukenberg Tumors of Gastric Origin: The Rationale of Surgical Resection and Perioperative Treatments in a Multicenter Western Experience 137
A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. 137
An aggressive early gastric cancer: Kodama's PenA type 137
Evidence of tumor microsatellite instability in gastric cancer with familial aggregation 136
The Role of Microsatellite Instability in Positive Margin Gastric Cancer Patients 136
Accuracy of MDCT in preoperative definition of maximum tumor diameter in patients with gastric cancer 135
Gastric cancer: Current status of lymph node dissection 135
Histological variety of gastric carcinoma and Helicobacter pylori cagA and vacA polymorphism 135
Treatment of the intraabdominal abscesses through percutaneous ultrasound-guided drainage in oncological patients: Clinical and microbiological data. 134
Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance status 134
Complications after gastrectomy for cancer: Italian perspective 134
Assessing the feasibility of full robotic interaortocaval nodal dissection for locally advanced gastric cancer 133
Totale 15.802
Salva come PNG Salva come JPEG
Categoria #
all - tutte 123.987
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.987
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.975 0 0 646 1.275 472 596 661 1.056 720 706 314 529
2020/20215.894 226 728 176 641 249 654 234 903 703 464 487 429
2021/20224.288 375 532 279 293 218 167 208 147 224 463 477 905
2022/20236.027 352 384 815 860 587 1.320 146 465 601 177 171 149
2023/20244.563 220 133 373 163 149 1.211 1.676 82 24 161 59 312
2024/20251.568 313 517 738 0 0 0 0 0 0 0 0 0
Totale 38.307